Cite
HARVARD Citation
Zuo, H. et al. (2022). A novel immunochemotherapy based on immunogenicity-activated and immunosuppression-reversed biomimetic nanoparticles. RSC advances. 12 (43), pp. 28104-28112. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Zuo, H. et al. (2022). A novel immunochemotherapy based on immunogenicity-activated and immunosuppression-reversed biomimetic nanoparticles. RSC advances. 12 (43), pp. 28104-28112. [Online].